Patients will have access via the Cancer Drugs Fund -LRB- CDF -RRB- until it is considered for routine NHS use
Each year an estimated 600 women with advanced cervical cancer could benefit from Avastin
The drug 's use was accelerated by the US Food and Drug Administration which approved Avastin plus chemotherapy for advanced cervical cancer in August 2014
Nearly 3,000 women are diagnosed with cervical cancer in the UK each year
' Trial findings show Avastin combined with chemotherapy can extend the lives of women with advanced cervical cancer by 26 per cent compared with chemotherapy alone
